Full-Time

Customer Success Manager

Posted on 6/18/2024

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Mid

Remote in UK

Category
Customer Success & Support
Customer Success Management
Sales & Account Management
Requirements
  • B.Sc. in a life science (M.Sc. or Ph.D. preferred)
  • At least three years of experience in a life sciences field related to drug discovery
  • Experience with computational chemistry or cheminformatics in a research setting
Responsibilities
  • Manage LiveDesign implementation projects from early-stage discussions through deployment, training, and growth
  • Ensure long-term customer success through use of the Schrödinger Platform
  • Collaborate internally with Account Managers, Applications Scientists, Solutions Architects, and the Education team to ensure success of the account by enabling substantial growth and usage
  • Help drive the product roadmap and development by working closely with product management and engineering, representing real-world customer needs

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by using sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and development through its platform, ultimately leading to the discovery of new drugs and therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools, enhancing drug safety.
  • Collaborations with companies like Avicenna improve Schrödinger's drug discovery efficiency.
  • Schrödinger's platform enables rapid exploration of chemical space, reducing development time.

What critics are saying

  • The Recursion and Exscientia merger creates a strong competitor in AI-driven drug discovery.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • Increasing drug discovery complexity may strain Schrödinger's resources and capabilities.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceuticals and academic institutions globally.
  • The company invests heavily in science and talent to enhance its computational platform.
  • Schrödinger's drug discovery programs span a broad range of therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE